Navigation Links
IFHP Study Reveals Disparity In Medical Costs Around The Globe
Date:3/26/2013

NEW YORK, March 26, 2013 /PRNewswire/ -- The International Federation of Health Plans today released its 2012 Comparative Price Report, detailing its annual survey of medical costs per unit. Designed to showcase the variation in healthcare costs around the world, the report examines the price of medical procedures, tests, scans and treatments in 12 countries, as well as the costs of six widely-prescribed drugs. The survey data showed that the United States continues to have the highest prices of those countries surveyed for both medical procedures and drugs.

For example, the average cost for a hospital day is $429 in Argentina, $665 in South Africa and an average of $4,287 in the U.S. A diagnostic procedure such as a colonoscopy will cost from an average of $413 in Argentina to $893 in the United Kingdom and $1,185 in the United States. The survey also found that the cost of a widely prescribed drug for depression, Cymbalta, can range from $47 in the France to $176, the average cost in the U.S.

As in prior surveys, the differential between unit prices was greatest for surgical procedures. One of the highest differentials was for C-sections: The range ran from $1,541 in Argentina to an average of $15,041 in the United States.

IFHP will host a conference call and Webinar with Chief Executive Tom Sackville at 10 a.m. PDT / 1 p.m. EDT on Tues., March 26, to discuss the findings. Details for joining the conference call and Webinar follow at the end of this news release.

"With the cost and availability of healthcare being an important topic around the world, it's essential that we not only examine the disparities that exist, but also why and how certain gaps do exist," said IFHP's Sackville.

Costs examined in the study included those from Argentina, Australia, Canada, Chile, France, Germany, India, New Zealand, South Africa, Spain, Switzerland and the United States. The data for the report was gathered from IFHP member organizations in each country.  

The IFHP was founded in 1968 by a group of health fund industry leaders, and is now the leading global network of the industry, with nearly 100 member companies across 25 countries. IFHP aims to assist in the maintenance of high ethical and professional standards throughout the industry. 

For a copy of the report and more information about IFHP, please visit www.ifhp.com.

Following are details for the conference call and Webinar to discuss the report findings:WHO:Tom Sackville, CEO of IFHPWHEN: 

Tuesday, March 2610 a.m. PDT/ 1 p.m. EDTWHERE: 

Remarks and Q&A session via conference call at (866) 901-4714 (U.S. and Canadian callers)(702) 599-4277 (callers outside United States and Canada)Conference ID: 26726254See the presentation online at: 

https://www.livemeeting.com/cc/edelman/join?id=FFMMB2&role=attend&pw=T%2F%7E5dhp
Meeting ID: FFMMB2
Entry Code: T/~5dhp

First Time Users:
To save time before the meeting, check your system to make sure it is ready to use Microsoft Office Live Meeting.

Troubleshooting
Unable to join the meeting? Follow these steps:

1.

Copy this address and paste it into your web browser: https://www.livemeeting.com/cc/edelman/join 2.

Copy and paste the required information: Meeting ID: FFMMB2Entry Code: T/~5dhpLocation: https://www.livemeeting.com/cc/edelman


'/>"/>
SOURCE International Federation of Health Plans
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: ... Annual Global Healthcare Conference at 9:15 a.m. ET on ... . David W. Meline , executive vice president ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
(Date:2/5/2016)... -- Redwood Scientific Technologies, Inc. announced today the development and ... balance their hormones. This product will be featuring Redwood,s ... Cardiff , President and CEO. "I am proud that ... of women across the country and around the world ... research and development team is confident that through the ...
(Date:2/5/2016)...  Syneron Medical Ltd. (NASDAQ: ELOS ), ... that William Griffing , Chief Executive Officer ... participate in the Leerink Partners 5 th ... in New York City . ... with the Mr. Griffing and will include a ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... The ... Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” campaign ... with muscular dystrophy, ALS and related diseases that severely limit strength and mobility. ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Give ... allow users to search for and donate to Give To Cure’s campaign that is ... app that lets users make and share payments through a smart device. In 2015 ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... practical mobile kitchens, recently announced the debut of their latest mobile kitchen model, ... Kitchens provides organizations with modern, high-volume commercial kitchens for use anywhere in the ...
Breaking Medicine News(10 mins):